
About Cytopot
Cytopot was a Healthcare company based in Scottsdale (United States) founded in 2019. It offers a comprehensive online platform for booking doctor appointments. It operates on a B2C model. Its Indian entity Nectarsday Healthcare Private Limited reported revenue of βΉ7.3 Lakh. The company is recorded as dissolved. Its focus areas include Health Technology, Telemedicine and Appointment Booking. Its competitors include Zocdoc, Ochsner and Hydreight; 1 of its 3 listed competitors has raised funding.
Company details
Cytopot, based in Scottsdale, focuses on providing healthcare solutions, advancing health solutions through tech, telemedicine, and appointment booking. Offers a comprehensive online platform for booking doctor appointments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Scottsdale, United States
- SectorsHealthcare
- Website cytopot.com
- Legal Name Nectarsday Healthcare Private Limited
- Date of Incorporation 28 Feb, 2019
- Jurisdiction Balasore, Odisha, India
- Indian entity revenue₹7.3 Lakh
FY 2022
- Indian entity net loss-₹94,533
FY 2022 · -13% margin
- Indian entity EBITDA-₹49,262
FY 2022 · -7% margin
Associated legal entities of Cytopot
Cytopot operates through Nectarsday Healthcare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nectarsday Healthcare Private Limited CIN U85110OR2019PTC030611 | Active | 28 Feb 2019 | Balasore, Odisha | ₹0.1 Cr | 2 | View details |
Board of directors of Nectarsday Healthcare Private Limited (Cytopot)
Nectarsday Healthcare Private Limited is the primary company behind Cytopot. The board of Nectarsday Healthcare Private Limited currently have 2 directors; the longest-serving is Abhijit Upadhyaya, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhijit Upadhyaya DIN 08296994 | Director | 28 Feb 2019 | 7 yrs 8 mo | Nectarsday Healthcare Private Limited |
| Nibedita Upadhyaya DIN 08296995 | Director | 28 Feb 2019 | 7 yrs 8 mo | Nectarsday Healthcare Private Limited |
Financials of Cytopot
Figures of Nectarsday Healthcare Private Limited, the primary company behind Cytopot, for FY 2022. Revenue was ₹7.3 Lakh. Net loss was -₹94,533 (-13% margin). EBITDA was -₹49,262 (-7% margin).
- ₹7.3 LakhRevenue · FY 2022
- -₹94,533Net loss · -13% margin
- -₹49,262EBITDA · -7% margin
- ₹5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Nectarsday Healthcare Private Limited are on its company page.
Detailed financial statements for Cytopot
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Cytopot
Cytopot has 3 listed competitors in our database, 1 of them funded. They include Zocdoc, Ochsner and Hydreight.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zocdoc.com | 2007 | New York, United States | $375.97M | 564 | Healthcare appointments are booked online via Zocdoc's platform. | |
| ochsner.org | 1942 | United States | 19,595 | Healthcare services, research, education, and community support are provided. | ||
| hydreight.com | 2018 | Las Vegas, United States | Online doctor appointments are booked via Hydreight's mobile platform. |
Detailed competitors of Cytopot
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Digital Health & Telemedicine
3 companies that operate in the same segment as Cytopot (Digital Health & Telemedicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
An application is provided for comparing prescription drug prices nationwide. | 2011 | Santa Monica, California, United States | USD 22.21 M | USD 796.85 M | 1,063 | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cytopot
Cytopot was founded in 2019.
Cytopot is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
The primary company behind Cytopot, Nectarsday Healthcare Private Limited, reported revenue of βΉ7.3 Lakh for FY 2022.
Cytopot, based in Scottsdale, focuses on providing healthcare solutions, advancing health solutions through tech, telemedicine, and appointment booking. Offers a comprehensive online platform for booking doctor appointments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Cytopot operates through Nectarsday Healthcare Private Limited.
The legal entities of Cytopot currently have 2 directors, including Abhijit Upadhyaya, Nibedita Upadhyaya.